Cambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company ...

AstraZeneca has allocated $3.5billion to expand its US manufacturing and research footprint by the end of 2026. The funding ...

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Chief Executive Officer Pascal Soriot buys 20,000 shares at GBP102.03, worth GBP2.0 million, on Thursday.

That’s what has fascinated the editors of Canada’s Top 100 Employers since the annual competition launched in 2000 to ...